User profiles for Brian Simons

Brian W Simons

Baylor College of Medicine
Verified email at bcm.edu
Cited by 3314

Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology …

…, P Martin, S Signoretti, R Sullivan, BW Simons… - Cancer research, 2013 - AACR
Animal models, particularly mouse models, play a central role in the study of the etiology,
prevention, and treatment of human prostate cancer. While tissue culture models are extremely …

Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation

…, E Lee, P Adstamongkonkul, BW Simons… - Science …, 2017 - science.org
Mucoadhesive particles (MAP) have been widely explored for pulmonary drug delivery
because of their perceived benefits in improving particle residence in the lungs. However, …

Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal …

…, D Maciaczyk, S Doostkam, BA Orr, B Simons… - Cancer letters, 2012 - Elsevier
Here we show that activation of the canonical WNT/β-catenin pathway increases the expression
of stem cell genes and promotes the migratory and invasive capacity of glioblastoma. …

Nanoparticle interactions with immune cells dominate tumor retention and induce T cell–mediated tumor suppression in models of breast cancer

…, XC Zhou, W Fu, C Hu, S Sukumar, BW Simons… - Science …, 2020 - science.org
The factors that influence nanoparticle fate in vivo following systemic delivery remain an area
of intense interest. Of particular interest is whether labeling with a cancer-specific antibody …

Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer

…, J Cades, H Wang, S Chatterjee, BW Simons… - Oncogene, 2019 - nature.com
Patients with EGFR-mutant non-small-cell lung cancer (NSCLC) have significantly benefited
from the use of EGFR tyrosine kinase inhibitors (TKIs). However, long-term efficacy of these …

Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer

EM Schaeffer, L Marchionni, Z Huang, B Simons… - Oncogene, 2008 - nature.com
Cancer cells differentiate along specific lineages that largely determine their clinical and
biologic behavior. Distinct cancer phenotypes from different cells and organs likely result from …

TWIST1-WDR5-Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis

…, RP Gajula, RD Williams, B Nghiem, BW Simons… - Cancer research, 2017 - AACR
TWIST1 is a transcription factor critical for development that can promote prostate cancer
metastasis. During embryonic development, TWIST1 and HOXA9 are coexpressed in mouse …

Notch signaling in prostate cancer: a moving target

FLF Carvalho, BW Simons, CG Eberhart… - The …, 2014 - Wiley Online Library
INTRODUCTION By regulating cell fate, proliferation, and survival, Notch pathway signaling
provides critical input into differentiation, organization, and function of multiple tissues. …

Vaginal delivery of paclitaxel via nanoparticles with non‐mucoadhesive surfaces suppresses cervical tumor growth

…, Q Zeng, B Miao, BC Tang, BW Simons… - Advanced …, 2014 - Wiley Online Library
Local delivery of chemotherapeutics in the cervicovaginal tract using nanoparticles may reduce
adverse side effects associated with systemic chemotherapy, while improving outcomes …

A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression

BW Simons, NM Durham, TC Bruno… - The Journal of …, 2015 - Wiley Online Library
Inflammation is associated with several diseases of the prostate including benign enlargement
and cancer, but a causal relationship has not been established. Our objective was to …